Nisa Investment Advisors LLC recently invested $53000 in Elanco Animal Health ($NYSE:ELAN) Incorporated, according to Defense World. Elanco Animal Health Incorporated is a global animal health company that develops, manufactures, distributes, and sells a wide range of animal health products and services for livestock, poultry, and companion animals. The company’s portfolio includes pharmaceuticals, vaccines, diagnostics, and other products for animal care.
Additionally, Elanco Animal Health provides products and services that help customers improve animal health and productivity, reduce the spread of diseases, and maximize the value of their animals. Elanco also works with researchers and veterinarians to develop new solutions for better animal health and performance. The company also engages in advocacy initiatives for animal health and welfare, partnering with industry peers and other organizations to promote responsible pet ownership and animal welfare across the world. With its innovative products, services, and initiatives, Elanco is well-positioned to become a leader in global animal health.
On Monday, ELANCO ANIMAL HEALTH was the center of attention in the stock market as the stock opened at $12.2 and closed at $12.1, gaining a 4.0% increase from its prior closing price of 11.6. This significant development was further bolstered by an investment of $53000 by Nisa Investment Advisors LLC. The company is engaged in the development, manufacturing and marketing of animal health products in several therapeutic categories.
It also offers services and solutions for the livestock and pet care industries. With such a notable investment from a well-known corporation, ELANCO ANIMAL HEALTH is sure to experience an upsurge in its stocks and a resulting increase in revenue. Live Quote…
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for ELAN. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for ELAN. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for ELAN. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for ELAN are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
Analysis – ELAN Stock Fair Value
We at GoodWhale have conducted an analysis of ELANCO ANIMAL HEALTH’s wellbeing. Our proprietary Valuation Line has determined that the intrinsic value of ELANCO ANIMAL HEALTH’s shares are around $23.0. However, the current stock is being traded at $12.1, meaning it is undervalued by 47.4%. This presents an exciting opportunity for investors who are looking to purchase shares at a discounted rate. As a leading stock market analysis firm, GoodWhale is proud to present this analysis and believe investors should take advantage of this undervalued stock. More…
Risk Rating Analysis
Star Chart Analysis
The company’s competitors include GeneFerm Biotechnology Co Ltd, Rhone Ma Holdings Bhd, and Phibro Animal Health Corp.
– GeneFerm Biotechnology Co Ltd ($TPEX:1796)
Ferm Biotechnology Co Ltd is a company that manufactures and sells biotechnology products. The company has a market cap of 2.34B as of 2022 and a return on equity of 9.05%. The company’s products are used in the healthcare, food and beverage, and industrial markets.
– Rhone Ma Holdings Bhd ($KLSE:5278)
Rhone Ma Holdings Bhd is a Malaysia-based investment holding company. The Company, through its subsidiaries, is engaged in the provision of management services, banking and financial services, and investment holding. The Company’s segments include Commercial Banking, which is engaged in the provision of banking products and services to small and medium enterprises (SMEs) and individuals; Treasury, which is engaged in the provision of foreign exchange and money market services; and Corporate Banking, which is engaged in the provision of financing solutions to SMEs and large corporations.
– Phibro Animal Health Corp ($NASDAQ:PAHC)
Phibro Animal Health Corp is a publicly traded company that focuses on animal health and nutrition. As of 2022, the company had a market capitalization of 505.49 million and a return on equity of 19.25%. Phibro Animal Health Corp was founded in 1947 and is headquartered in Teaneck, New Jersey. The company’s products include pharmaceuticals, vaccines, and nutritional supplements for livestock, poultry, and aquaculture.
Elanco Animal Health Incorporated is a leading global animal health company focused on providing products and services for food animals, companion animals and production animals. Analysts have noted that Elanco has demonstrated stability in earnings and revenue, as well as improved efficiency in research and development costs.
In addition, the company’s innovative products and services have allowed them to capitalize on the growing demand for animal health products and services globally. Investors should consider the potential for long-term growth in Elanco’s stock given its consistent performance, increasing market share and strong product pipeline. This recent investment indicates that Elanco Animal Health Incorporated could be a wise investment choice for those seeking long-term gains.